Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.

2025-01-1920230732-183Xhttps://hdl.handle.net/20.500.14288/26768OncologyComparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.Meeting abstract1527-77551098050200510N/A51203